Microbiome and bacteriophage preparations for animals
01Overview and value chain
Markers: [EC: EFSA scientific opinion pathway for feed/food microbial and phage additives | OECD: Agricultural biotechnology | Regulator: FDA (USA), EFSA (EU)]
Microbiome and bacteriophage preparations for animals cover two related but distinct product classes: direct-fed microbials that recondition the rumen or gut microbiome, and bacteriophage cocktails that kill a single target pathogen (Salmonella, E. coli, Listeria) while leaving the rest of the microbiome intact. Phage cocktails targeting multiple bacterial receptors have been shown to reduce Salmonella Enteritidis colonization in chicks while also reshaping the cecal microbiome, and phages isolated against ETEC K88 (F4) alleviate post-weaning diarrhea in piglets through the same dual mechanism — direct pathogen kill plus a secondary microbiota effect. Because a phage’s host range is typically limited to one bacterial species or even serotype, most commercial products ship as a cocktail of several phage strains to cover circulating pathogen diversity, and every new pathogen variant can in principle require an updated cocktail — a manufacturing model closer to a vaccine update than a fixed-molecule drug.
Key directions of microbiome and phage preparations for animals:
- Targeted bacteriophage cocktails (Targeted Bacteriophage Cocktails): multi-strain phage blends engineered to cover several receptor types of a single target pathogen (e.g., Salmonella, E. coli) in poultry or swine.
- Direct-fed rumen microbials (Direct-Fed Rumen Microbials): live microbial strains dosed to feedlot and dairy cattle to recondition the rumen microbiome and support growth performance.
- Food-chain surface phage biocontrol (Food-Chain Surface Phage Biocontrol): phage sprays applied to animal-origin food surfaces (poultry, meat) to control Salmonella/Listeria post-harvest.
- One Health phage regulatory frameworks (One Health Phage Regulatory Frameworks): emerging manufacturing-quality and governance standards that treat veterinary and food-contact phage products as a single regulatory family.
Sectoral value chain
[pathogen/strain surveillance] ──> [phage/microbial isolation] ──> [cocktail formulation] ──> [stability & delivery]
│
(efficacy trial)
│
▼
[on-farm/on-line application] <─── [regulatory review] <─────────────────┘Value chain levels
| Level | Description | Key inputs/outputs |
|---|---|---|
| Pathogen/Strain Surveillance | tracking circulating Salmonella/E. coli/Listeria strains | In: farm/plant isolates. Out: strain panel. |
| Isolation | isolating candidate phages or beneficial microbial strains | In: environmental samples. Out: candidate strain library. |
| Cocktail Formulation | combining several phage strains or microbials for coverage | In: candidate strains. Out: multi-strain cocktail. |
| Stability & Delivery | formulating for feed, water-line or surface-spray delivery | In: cocktail, carriers. Out: stable product format. |
| Efficacy Trial | on-animal or on-surface pathogen-reduction trials | In: trial animals/surfaces. Out: log-reduction/colonization data. |
| Regulatory Review | FDA/EFSA review of a feed or food-contact biocontrol agent | In: trial dossier. Out: market authorization. |
Cross-cutting technologies of the sector:
- Multi-receptor phage cocktails (Multi-Receptor Phage Cocktails): blends targeting several bacterial surface receptors at once to slow resistance emergence.
- Direct-fed microbial strain banks (Direct-Fed Microbial Strain Banks): curated live microbial libraries selected for rumen/gut performance traits.
- Post-harvest surface spray application (Post-Harvest Surface Spray Application): misting, spraying or dipping phage solutions directly onto animal-origin food surfaces.
02US
The US hosts the leading dedicated bacteriophage manufacturers spanning both live-animal and food-surface applications, plus a distinct direct-fed rumen microbial platform.
FDA food-contact substance listings, poultry water-line phage delivery, rumen microbial patents
- Intralytix: bacteriophage products spanning live-poultry water-line Salmonella control and food-contact surface treatment, built on broad-host-range phage isolates such as GSP006.
- Native Microbials: a patented rumen microbial composition platform; a direct-fed microbial product line shown in feedlot-cattle trials to affect growth performance.
- Certis Biologicals (AgriPhage SalmoPro): a bacteriophage-based Salmonella-control product for food-processing environments, extending an agricultural-biocontrol phage platform into food-chain biosecurity.
03CN
Public information on a dedicated Chinese originator of livestock-facing bacteriophage or rumen-microbial products at the scale of the US/EU leaders was not confirmed in this pass; the section stays at the policy level.
veterinary drug administration oversight, feed additive registration, university phage research
- MARA veterinary biologics oversight: bacteriophage and live-microbial animal products fall under China’s veterinary biologics and feed-additive registration regimes rather than a dedicated phage category.
- University-led phage isolation programs: Chinese agricultural universities publish poultry- and swine-pathogen phage characterization work, but a named commercial originator was not confirmed in this pass.
- Import/licensing pathway: as with several biocontrol categories, US/EU-originated phage products are more likely to reach the Chinese market via licensing or distribution than domestic origination at this stage.
04EU
The EU is home to a leading food-safety bacteriophage manufacturer and to the scientific-opinion process that is beginning to treat veterinary and food-contact phage products under a shared “One Health” governance model.
EFSA scientific opinions, PhageGuard product family, One Health governance roadmap
- Micreos (PhageGuard): Listeria- and Salmonella-targeting bacteriophage sprays for food production surfaces, positioned within a broader “Phages for One Health” regulatory and product-lifecycle framework.
- EFSA scientific opinion pathway: feed and food microbial/phage additives (e.g., a 2026 positive opinion on a poultry-fattening bacteria probiotic) go through EFSA efficacy review ahead of EU market authorization.
- One Health phage roadmap: a 2026 review sets out manufacturing-quality, regulatory-governance and ethical-stewardship expectations spanning both veterinary and food-contact phage products.
05Leading companies and research institutes
| Company / Institute | Country | Key products / platforms | Tech features | Status 2026 |
|---|---|---|---|---|
| Intralytix | 🇺🇸 USA | Poultry water-line & surface phage products | broad-host-range Salmonella phage isolates (e.g. GSP006) | Commercial |
| Native Microbials | 🇺🇸 USA | Rumen direct-fed microbial platform | patented microbial compositions for ruminant performance | Commercial |
| Micreos | 🇳🇱 Netherlands | PhageGuard Listeria / Salmonella | food-surface phage spray/mist/dip application | Commercial |
| Certis Biologicals | 🇺🇸 USA | AgriPhage SalmoPro | Salmonella-control phage for food-processing environments | Commercial |
06Tech stack and innovations
The stack pairs narrow-spectrum biological kill with formulation engineering for shelf-stable delivery.
- Multi-receptor phage cocktail design (Multi-Receptor Phage Cocktail Design):
- combining phages that bind different bacterial surface receptors reduces the chance that a single resistant mutant escapes the whole cocktail.
- case: a multi-receptor cocktail reduced Salmonella Enteritidis colonization in chicks while also reshaping the cecal microbiome.
- Rumen direct-fed microbial selection (Rumen Direct-Fed Microbial Selection):
- candidate strains are screened from rumen/gut samples for performance and health traits before being formulated as a live product.
- case: a novel direct-fed microbial measurably affected growth performance in a feedlot-cattle trial.
- Post-harvest surface-spray phage delivery (Post-Harvest Surface-Spray Phage Delivery):
- phage solutions are misted, sprayed or dipped directly onto meat and poultry surfaces late in processing, after the live-animal stage.
- case: PhageGuard-type products are positioned specifically as a post-harvest Listeria/Salmonella control step rather than an on-farm treatment.
07Value chains and production pipelines
Industrial pipeline of a targeted bacteriophage cocktail (EFSA/FDA biocontrol review)
┌───────────────────────────┐ ┌───────────────────────────┐
│ 1. Pathogen surveillance │ ───> │ 2. Phage isolation │
└───────────────────────────┘ └───────────────────────────┘
│
▼
┌───────────────────────────┐ ┌───────────────────────────┐
│ 4. Efficacy trial │ <─── │ 3. Cocktail formulation │
└───────────────────────────┘ └───────────────────────────┘
│
▼
┌───────────────────────────┐ ┌───────────────────────────┐
│ 5. Regulatory review │ ───> │ 6. Farm/plant deployment │
└───────────────────────────┘ └───────────────────────────┘Stage 1: Pathogen surveillance
Farm and processing-plant isolates of Salmonella, E. coli or Listeria strains are tracked to identify the circulating pathogen profile a cocktail must cover.
Stage 2: Phage isolation
Candidate phages are isolated from environmental samples and characterized for host range against the surveilled pathogen panel.
Stage 3: Cocktail formulation
Several phage strains binding different bacterial receptors are combined into a single multi-strain product to slow resistance emergence.
Stage 4: Efficacy trial
On-animal (e.g., chick colonization) or on-surface trials quantify pathogen reduction and any secondary microbiome effect.
Stage 5: Regulatory review
FDA food-contact-substance review or an EFSA scientific opinion assesses the trial dossier ahead of market authorization.
Stage 6: Farm/plant deployment
The product is applied via drinking water, feed or a post-harvest surface spray, with pathogen levels audited against the pre-treatment baseline.
| Supplier | Price | Certificates | Risk | Confidence |
|---|---|---|---|---|
| Intralytix | on request | Medium | MEDIUM | |
| Native Microbials | on request | Low | MEDIUM | |
| Micreos | on request | Low | MEDIUM | |
| Certis Biologicals | on request | Low | MEDIUM |
AI note: microbiome-phage-preparations-animals (EN)
Key directions:
- Targeted bacteriophage cocktails — multi-strain phage blends covering several receptor types of one target pathogen (Salmonella, E. coli) in poultry/swine.
- Direct-fed rumen microbials — live microbial strains dosed to cattle to recondition the rumen microbiome and support growth performance.
- Food-chain surface phage biocontrol — phage sprays on animal-origin food surfaces to control Salmonella/Listeria post-harvest.
- One Health phage regulatory frameworks — emerging governance standards treating veterinary and food-contact phage products as one family.
Regulatory:
- US: FDA reviews phage products as food-contact substances/feed additives; no single dedicated phage statute.
- EU: EFSA scientific-opinion pathway covers both microbial and phage feed/food additives; a 2026 review proposes shared One Health manufacturing-quality standards across veterinary and food-contact phage products.
- China: bacteriophage and live-microbial animal products fall under MARA’s veterinary biologics/feed-additive registration regimes; no dedicated commercial originator at US/EU scale confirmed in this pass.
Companies not in table: this article’s Intralytix row focuses on its animal-agriculture phage products (poultry water-line/surface treatment), distinct from the sibling bacteriophage-therapy article’s human-medicine focus on the same company — kept separate to avoid duplicating prose, not to duplicate the entity; CH4 Global and a India-focused AMR livestock research protocol (Nagpur, India) were investigated but excluded — the former duplicates the already-published methane-reduction-ruminants article’s ground, the latter is a research study protocol with no named commercial entity to anchor a table row.
Processing note: because phage host range is typically limited to one species or serotype, nearly every commercial product ships as a multi-strain cocktail rather than a single-molecule product — the closest analogy is a vaccine update cycle rather than a fixed small-molecule drug, which is also why post-harvest surface-spray products (Micreos, Certis) and live-animal water-line products (Intralytix) are formulated and regulated somewhat differently despite sharing the same phage-biology base.
Relevance: this is one of the clearest antibiotic-alternative categories with dual food-safety and animal-welfare framing — a single trial can show both direct pathogen kill and a secondary, beneficial microbiome shift, which is the evidence base regulators increasingly ask for. The absence of a confirmed China-based originator at this scale is the sharpest open gap found in this pass.